Tg. Redgrave et al., Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test, J LIPID RES, 42(5), 2001, pp. 710-715
We have developed a stable isotope breath test for the assessment of chylom
icron remnant metabolism and report the results from the breath test in hum
an subjects selected for disorders of chylomicron or remnant metabolism. In
type I hyperlipemia, the phenotype is extreme hypertriglyceridemia due to
a lack of lipoprotein lipase activity, which causes the failure of remnant
formation, The type UI dyslipidemia phenotype is caused by the inefficient
removal of chylomicron remnants from plasma, generally because of homozygos
ity for apolipoprotein E2 alleles. The breath test was predicted to be abno
rmal in type m hyperlipemia, whereas a priori in type I hyperlipemia defect
ive remnant clearance was not anticipated. Subjects were injected with lipi
d emulsions prepared with a composition similar to normal chylomicron remna
nts. The emulsions contained cholesteryl ester incorporating the stable non
radioactive isotope C-13 in the fatty acid moiety, End exhalation breath wa
s collected at intervals after intravenous injection of the remnant-like em
ulsions and analyzed for C-13 enrichment by isotope-ratio mass spectrometry
. Compared with the group of normolipemic men, the fractional catabolic rat
e of remnants measured by the breath test was significantly decreased (P =
0.006) in subjects with type m dyslipidemia. In the group with type I hyper
lipemia, the fractional catabolic rate was not different (P = 0.233) from t
he control group, Therefore, the underlying capacity for remnant catabolism
j/r normal in this group of markedly hypertriglyceridemic subjects.j/r By
shortcircuiting the step of lipolysis, the remnant-like emulsion breath tes
t provides direct information about remnant clearance and metabolism, which
should assist in investigations of postprandial lipid metabolism.-Redgrave
, T G., G. F. Watts, I. J. Martins, P. H. R. Barrett, J. C. L. Mamo, S. B.
Dimmitt, and A. D. Marais. Chylomicron remnant metabolism in familial dysli
pidemias studied with a remnant-like emulsion breath test.